282 related articles for article (PubMed ID: 8356981)
41. Antiphospholipid antibodies in primary Sjögren's syndrome: prevalence and clinical significance in a series of 80 patients.
Cervera R; García-Carrasco M; Font J; Ramos M; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ingelmo M
Clin Exp Rheumatol; 1997; 15(4):361-5. PubMed ID: 9272295
[TBL] [Abstract][Full Text] [Related]
42. The blood-brain barrier, TWEAK, and neuropsychiatric involvement in human systemic lupus erythematosus and primary Sjögren's syndrome.
Lauvsnes MB; Tjensvoll AB; Maroni SS; Kvivik I; Grimstad T; Greve OJ; Harboe E; Gøransson LG; Putterman C; Omdal R
Lupus; 2018 Nov; 27(13):2101-2111. PubMed ID: 30282561
[TBL] [Abstract][Full Text] [Related]
43. Primary systemic Sjögren syndrome (SS) preceding systemic lupus erythematosus: a retrospective study of 4 cases in a cohort of 55 SS patients.
Zufferey P; Meyer OC; Bourgeois P; Vayssairat M; Kahn MF
Lupus; 1995 Feb; 4(1):23-7. PubMed ID: 7767334
[TBL] [Abstract][Full Text] [Related]
44. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
[TBL] [Abstract][Full Text] [Related]
45. Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity.
Alexander EL; Arnett FC; Provost TT; Stevens MB
Ann Intern Med; 1983 Feb; 98(2):155-9. PubMed ID: 6600593
[TBL] [Abstract][Full Text] [Related]
46. Clinical and biological aspects of anti-P-ribosomal protein autoantibodies.
Toubi E; Shoenfeld Y
Autoimmun Rev; 2007 Jan; 6(3):119-25. PubMed ID: 17289545
[TBL] [Abstract][Full Text] [Related]
47. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
[TBL] [Abstract][Full Text] [Related]
48. Autoantibodies in central nervous system lupus.
Hay EM; Isenberg DA
Br J Rheumatol; 1993 Apr; 32(4):329-32. PubMed ID: 8461927
[TBL] [Abstract][Full Text] [Related]
49. Predictors for future development of systemic lupus erythematosus in Korean Sjögren's syndrome patients.
Lee BW; Kwon EJ; Park Y; Lee JJ; Ju JH; Park SH; Kwok SK
Lupus; 2023 Oct; 32(12):1359-1368. PubMed ID: 37751679
[TBL] [Abstract][Full Text] [Related]
50. Anti-ribosomal-P antibodies in a Sjögren syndrome patient associated with lupus erythematosus.
Muro Y; Tomita Y
J Dermatol; 2004 Oct; 31(10):811-4. PubMed ID: 15672709
[TBL] [Abstract][Full Text] [Related]
51. Neurologic disease in Sjögren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis.
Alexander EL
Rheum Dis Clin North Am; 1993 Nov; 19(4):869-908. PubMed ID: 8265827
[TBL] [Abstract][Full Text] [Related]
52. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases.
Kang EH; Shen GQ; Morris R; Metzger A; Lee EY; Lee YJ; Lee EB; Song YW
Lupus; 2008 Jan; 17(1):21-5. PubMed ID: 18089679
[TBL] [Abstract][Full Text] [Related]
53. The importance of alpha-fodrin antibodies in the diagnosis of Sjögren's syndrome.
Turkçapar N; Olmez U; Tutkak H; Duman M
Rheumatol Int; 2006 Feb; 26(4):354-9. PubMed ID: 15990993
[TBL] [Abstract][Full Text] [Related]
54. Anti-P antibodies and neuropsychiatric lupus erythematosus.
Georgescu L; Mevorach D; Arnett FC; Reveille JD; Elkon KB
Ann N Y Acad Sci; 1997 Aug; 823():263-9. PubMed ID: 9292053
[TBL] [Abstract][Full Text] [Related]
55. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
[TBL] [Abstract][Full Text] [Related]
56. Serum complement activation in central nervous system disease in Sjögren's syndrome.
Alexander EL; Provost TT; Sanders ME; Frank MM; Joiner KA
Am J Med; 1988 Oct; 85(4):513-8. PubMed ID: 3177398
[TBL] [Abstract][Full Text] [Related]
57. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions.
Kelly MC; Denburg JA
J Rheumatol; 1987 Aug; 14(4):740-4. PubMed ID: 3668979
[TBL] [Abstract][Full Text] [Related]
58. The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjögren's syndrome.
He J; Qiang L; Ding Y; Wei P; Li YN; Hua H; Li ZG
Clin Exp Rheumatol; 2012; 30(3):322-6. PubMed ID: 22510450
[TBL] [Abstract][Full Text] [Related]
59. Autoantibodies in neuropsychiatric lupus.
Greenwood DL; Gitlits VM; Alderuccio F; Sentry JW; Toh BH
Autoimmunity; 2002 Mar; 35(2):79-86. PubMed ID: 12071439
[TBL] [Abstract][Full Text] [Related]
60. A novel association of osmotic demyelination in Sjögren's syndrome prompts revisiting role of aquaporins in CNS demyelinating diseases: A literature review.
Sandhya P; Akaishi T; Fujihara K; Aoki M
Mult Scler Relat Disord; 2023 Jan; 69():104466. PubMed ID: 36584554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]